Publications by authors named "Jim Gamez"

Claim this Profile
D
Discovery and Characterization of Novel BLIMP-1 Heterobifunctional Ligand-Directed Degraders.
Bryan J Simmons, Lynda Groocock, Jesus Moreno, David S Peters, Meredith E Hughes, Jim Gamez

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760.
Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes, William Thomas, Diogo Da Silva, Jim Gamez

J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase.
Deborah S Mortensen, John Sapienza, Branden G S Lee, Sophie M Perrin-Ninkovic, Roy Harris, Jim C Gamez

Bioorg Med Chem Lett· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
Ling-Hua Zhang, Lei Wu, Heather K Raymon, Roger S Chen, Laura Corral, Jim Gamez

Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis